KLSE (MYR): DCHCARE (0283)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.21
Today's Change
-0.005 (2.33%)
Day's Change
0.205 - 0.215
Trading Volume
4,500,100
T4Q
31-Mar-2021
2020
31-Mar-2021
2019
31-Mar-2021
2018
31-Mar-2021
2017
31-Mar-2021
There was an announcement on March 6th, 2024:
Reference is made to the announcement dated 22 December 2023 whereby M&A Securities had on behalf of the Company, announced that the additional listing application for the Proposals and the draft circular to shareholders in relation to the Proposals have been submitted to Bursa Securities for approval on the even date (“Listing Application”).
On behalf of the Board, M&A Securities wishes to announce that the Company has submitted an application to Bursa Securities for the withdrawal of the Listing Application (“Withdrawal Application”).
The decision of the Board was made in order to review the structure of the Proposed Acquisition (and consequently the Proposed Variation). The Board shall make the necessary announcement on the revised proposal in due course.
hope they will review and lower the acquisition price...
1 month ago
I just read the press release on April 18th.
In 2024, DC Healthcare has expanded its reach by opening four Dr. Chong Clinics located in
- Taman Molek (Johor Bahru) opened in 2024 February
- Bandar Seri Botani (Ipoh) opened in 2024 February
- Auto City (Pulau Pinang) opened in 2024 February
- Publika (Kuala Lumpur) opened in 2024 April
as well as four DC Body outlets in
- Auto City (Pulau Pinang) opened in 2024 February
- USJ Taipan (Selangor) opened in 2024 March
- Publika (Kuala Lumpur) opened in 2024 April
- Bukit Indah (Johor Bahru) opened in 2024 April
With these latest additions, DC Healthcare now operates a total of 17 medical aesthetic clinics and 4 DC Body outlets nationwide
4 weeks ago
The annual report was out on April 30th, 2024.
Regarding expansion, management noted that:
Opening new clinics generally entails significant initial costs, such as leasing of properties, obtaining medical equipment, recruiting, hiring, training of medical and support staff. Such initial set up costs for new clinics can be a considerable expense before these facilities reach their full operating potential. These expenditures contribute to the challenge of achieving optimal financial performance until the new facilities reach full operational capacity.
... Additionally, the launch of new clinics necessitates robust marketing campaigns to establish a presence in new markets, impacting short-term financial performance. It’s important to note that new clinics may require time to attain the patient volume needed for optimal financial outcomes, leading to thinner margins during the initial phase.
3 weeks ago
so did the company utilize 70mil from the reserve to acquire the 2 small clinics?
5 days ago
Get ready for the rally when its Q1 results are announced. Capture the coming rally at current cheap prices 😉
2 days ago
Dr Chong become Dr Con, spending money on all useless acquisition and revenue drop by almost 50%, exit while its not too late
1 day ago
Ouch.... Thought it would be good ... let's see how it goes when the market is open later
1 day ago
I love Dr Chong, after TP , now when people sell off, then is my time to buy it back.
1 day ago
revenue was down 44% , "mainly due to the lower redemption rate in aesthetic services."
not sure what it means... totally unexpected
1 day ago
profit was expected to be lower because of the costs of new outlets and marketing cost. Anyway, revenue was down 44%, now that's a different story. It's horrible!
1 day ago
ipo prospectus shows past results were profitable. Now seems they face challenges in making profits after ipo....
1 day ago
The change of revenue recognition from 3 months to 12 months is simply a matter of time and a different point of view, as most of the stock will also not instantly reflect the result.
1 day ago
Seems like 0.22 is the bottom price.. 2nd half of the year business should slowly improve
1 day ago
They sell aesthetic products in packages. The low redemption rate indicates that people have purchased the packages but have not yet used them. They can only recognize revenue when the customer redeems the package.
1 day ago
@mudaBubu
then where do you check those un-recognize revenue in the report? if not hard convince us as the revenue slump 50%~ which is terrifying
1 day ago
@mudaBubu
is there a way to find out the amount of money customers brought in in the previous quarter (3 months):
amount of money customers brought in and redeemed
amount of money customers brought in and not yet redeemed
we can add these 2 figures to know the amount of money customers brought in
or is there any figure that will help us to know how much revenue (recognized and unrecognized) is generated in previous 3 months.
Thank you in advance!
1 day ago
why can't the company recognize the revenue from the product packages paid by the customers where the amount of money paid is not refundable?
1 day ago
It's due to Malaysian Financial Reporting Standards, fortunefire. Under this MFRS, revenue can only be recognized when clients redeem their services.
1 day ago
There is a blog explaining the unrecognized revenue
The Truth Behind DC Healthcare Results!!
https://klse.i3investor.com/web/blog/detail/faizaleyes/2024-05-27-story-h-160716431-The_Truth_Behind_DC_Healthcare_Results
Contract liabilities
There are 2 Contract liabilities figures in quarterly report. The figure 9,591(000) in the balance sheet as at 31.03.2024 must have included unrecognized revenue in the last quarter and also quarters before that.
as at 31.12.2023 3,709 (000)
as at 31.03.2024 9,591(000)
there is an increase of 5882 (000) from Q4FY2023 to Q1FY2024
This Contract liabilities figure of 5,882 (000) found in the cash flow statement for the first quarter ended 31.03.2024 is the unrecognized revenue generated in the last quarter ALONE.
for Q1FY2024:
total sales = revenue 9,454 (000) + Contract liabilities 5,882 (000) = 15336 (000)
not too bad. This figure is lower than last year Q1FY2023
for Q1FY2023
total sales = revenue 16,811 (000) + Contract liabilities 68 (000) = 16879 (000)
20 hours ago
Then we can anticipate DCHCARE's financial performance will improve in the next quarter
20 hours ago
dont be naive, such niche market hardly grow significant in 1 or 2 quarter. it take years and years to prove it.
better find something that more promising with history performance record
19 hours ago
Facial and slim program like consumable item, you must go for treatment every month. I dont understand why the half of previous package buyer suddenly didn't turn out during the past quarter. One possible is DC doing buy one free one promotion pre-IPO, so the clients paid pre-IPO and thus now DC has higher liability. My wild guess.
18 hours ago
Like my wife does not go after bought the package. Now needing Rm for more important essentials in life. My wife forfeit the package la. I think maybe that’s the reason why…
You connect the dots laaa
18 hours ago
Time is getting tougher now. Rm is allocated for essential now. Non essential.. need to set aside for now. Haizzz
18 hours ago
this aesthetic business is a very competitive industry. blame the mfrs for not recognizing the revenue? come on!
17 hours ago
Higher contract liabilities from RM3.7 million to RM9.6 million is interesting, if I'm not wrong DCHCARE collects deposits from customer for the next 12 months' aesthetic services, from the initial 3 months. So the profits & revenue number are "interesting" right now.
17 hours ago
Hoot9ee
Time to go back 0.50
1 month ago